Antioxidant effect of the active metabolites of tibolone

References

• Gil del Valle L. Oxidative stress in aging: theoretical outcomes and clinical evidences in humans. Biomed Aging Pathol 2011;1:1–7
   Google Scholar
• Babior BM. Phagocytes and oxidative stress. Am J Med 2000;109:33–44
   PubMed Web of Science ®Google Scholar
• Kumar S, Lata K, Mukhopadhyay S, Mukherjee TK. Role of estrogen receptors in pro-oxidative and anti-oxidative actions of estrogens: a perspective. Biochim Biophys Acta 2010;1800:1127–35
   PubMed Web of Science ®Google Scholar
• Bekesi G, Kakucs R, Varbiro S, et al. In vitro effects of different steroid hormones on superoxide anion production of human neutrophil granulocytes. Steroids 2000;65:889–94
   PubMed Web of Science ®Google Scholar
• Viridis A, Taddei S. Endothelial aging and gender. Maturitas 2012;71:326–30
   Google Scholar
• Bekesi G, Racz K, Hrabak A, et al. Systematic investigation of different steroid precursors with respect to their effect on superoxide anion production by human neutrophil granulocytes. Horm Metab Res 2004;36:155–63
   PubMed Web of Science ®Google Scholar
• Bekesi G, Tulassay Z, Racz K, et al. The effect of estrogens on superoxide anion generation by human neutrophil granulocytes: possible consequences of the antioxidant defense. Gynecol Endocrinol 2007;23:451–4
   Web of Science ®Google Scholar
• Kloosterboer HJ. Historical milestones in the development of tibolone (Livial®). Climacteric 2011;14:609–21
   PubMed Web of Science ®Google Scholar
• Biglia N, Maffei S, Lello S, Nappi RE. Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials. Gynecol Endocrinol 2010;26:804–14
   PubMed Web of Science ®Google Scholar
• Cicinelli E, Ignarro LJ, Galantino P, et al. Effects of tibolone on plasma levels of nitric oxide in postmenopausal women. Fertil Steril 2002;78:464–8
   PubMed Web of Science ®Google Scholar
• Simoncini T, Mannella P, Fornari L, et al. Tibolone activates nitric oxide synthesis in human endothelial cells. J Clin Endocrinol Metab 2004;89:4594–600
   PubMed Web of Science ®Google Scholar
• de Aguiar RB, Dickel OE, Cunha RW, et al. Estradiol valerate and tibolone: effects upon brain oxidative stress and blood biochemistry during aging in female rats. Biogerontology 2008;9:285–98
   Google Scholar
• Petit E, Courtin A, Kloosterboer HJ, et al. Progestins induce catalase activities in breast cancer cells through PRB isoform: correlation with cell growth inhibition. J Steroid Biochem Mol Biol 2009;115:153–60
   PubMed Web of Science ®Google Scholar
• Guarnieri C, Melandri G, Caldarera I. Reduced oxidative activity of circulating neotrophils in patients after myocardial infarction. Cell Biochem Funct 1990;8:157–62
   Google Scholar
• Jansson G. Oestrogen-induced enhancement of myeloperoxidase activity in human polymorphonuclear leukocytes – a possible cause of oxidative stress in inflammatory cells. Free Radic Res Commun 1991;14:195–208
   PubMed Web of Science ®Google Scholar
• Bekesi G, Kakucs R, Sandor J, et al. Plasma concentration of myeloperoxidase enzyme in pre- and postclimacterial people: related superoxide anion generation. Exp Gerontol 2001;37:137–48
   PubMed Web of Science ®Google Scholar
• Vos RM, Krebbers SF, Verhoeven CH, Delbressine LP. The in vivo human metabolism of tibolone. Drug Metab Dispos 2002;30:106–12
   PubMed Web of Science ®Google Scholar
• Takanashi K, Watanabe K, Yoshizawa I. On the inhibitory effect of C17-sulfoconjugated catechol estrogens upon lipid peroxidation of rat liver microsomes. Biol Pharm Bull 1995;18:1120–5
   PubMed Web of Science ®Google Scholar
• Lodi F, Jimenez R, Moreno L, et al. Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta. Atherosclerosis 2009;204:34–9
   Google Scholar
• Iwasaki Y, Asai M, Yoshida M, et al. Dehydroepiandrosterone-sulfate inhibits nuclear factor-kappaB-dependent transcription in hepatocytes, possibly through antioxidant effect. J Clin Endocrinol Metab 2004;89:3449–54
   PubMedGoogle Scholar
• Vassalle C, Cicinelli E, Lello S, et al. Effects of menopause and tibolone on different cardiovascular biomarkers in healthy women. Gynecol Endocrinol 2011;27:163–9
   PubMed Web of Science ®Google Scholar
• Sartore A, Grimaldi E, Guaschino S. The treatment of Sjögren's syndrome with tibolone: a case report. Am J Obstet Gynecol 2003;189:894
   Google Scholar
• Zandberg P, Peters JLM, Demacker PNM, et al. Tibolone prevents atherosclerotic lesion formation in cholesterol-fed, ovariectomized rabbits. Arterioscler Thromb Vasc Biol 1998;18:1844–54
   PubMed Web of Science ®Google Scholar
• Sator K, Sator MO, Sator PG, et al. Effects of tibolone on selectins in postmenopausal women. Maturitas 2006;53:166–70
   PubMed Web of Science ®Google Scholar
• Foley P, Gerlach M, Youdim MB, Riederer P. MAO-B inhibitors: multiple roles in the therapy of neurodegenerative disorders? Parkinsonism Relat Disord 2000;6:25–47
   PubMed Web of Science ®Google Scholar
• Benzie IF, Tomlinson B. Antioxidant power of angiotensin-converting enzyme inhibitors in vitro. Br J Clin Pharmacol 1998;45:168–9
   PubMed Web of Science ®Google Scholar
• Keles MS, Bayir Y, Suleyman H, Halici Z. Investigation of effects of Lacidipine, Ramipril and Valsartan on DNA damage and oxidative stress occurred in acute and chronic periods following isoproterenol-induced myocardial infarct in rats. Mol Cell Biochem 2009;328:109–17
   PubMed Web of Science ®Google Scholar
• Gáspárová Z, Ondrejičková O, Gajdošíková A, et al. Oxidative stress induced by the Fe/ascorbic acid system or model ischemia in vitro: effect of carvedilol and pyridoindole antioxidant SMe1EC2 in young and adult rat brain tissue. Interdiscip Toxicol 2010;3:122–6
   PubMedGoogle Scholar
• Murrow JR, Sher S, Ali S, et al. The differential effect of statins on oxidative stress and endothelial function: atorvastatin versus pravastatin. J Clin Lipidol 2012;6:42–9
   PubMed Web of Science ®Google Scholar
• Heller FR, Descamps O, Hondekijn JC. LDL oxidation: therapeutic perspectives. Atherosclerosis 1998;137:S25–31
   Google Scholar